Winselow Tucker is the Senior Vice President and Chief Commercial Officer for Oncology at Lilly’s oncology unit Loxo@Lilly.
In this role, he is responsible for leading the commercialization activities for the oncology business of Lilly, including leading U.S. and global teams in the development of go to markets strategies, new product development activities associated with launches and leadership of the U.S. oncology business.
Before Eli Lilly, Winselow was the Senior Vice President, Intercontinental, at Bristol Myers Squibb where he had responsibility overseeing a diverse and dynamic multinational region, with responsibility for 70+ countries across five continents, including China, Asia, Australia, Central & Eastern Europe, Latin America, Brazil, and the Middle East.
Winselow has over 20 years of pharmaceutical and biotech experience delivering strong business results and successfully launching new products.
Winselow has also held senior positions of increasing responsibility leading teams in the U.S. and globally in general manager and commercial roles at Celgene and Novartis.
Winselow obtained a Bachelor of Business Administration degree from Howard University and earned his MBA in Marketing and Finance from Indiana University’s Kelley School of Business.
